Research analysts at Evercore ISI started coverage on shares of Iqvia (NYSE:IQV) in a note issued to investors on Thursday, The Fly reports. The firm set an “outperform” rating on the medical research company’s stock.
A number of other research firms have also recently commented on IQV. KeyCorp reissued a “sector weight” rating and set a $100.00 price target on shares of Iqvia in a report on Friday, November 10th. Credit Suisse Group reissued an “outperform” rating and set a $110.00 price target (up from $98.00) on shares of Iqvia in a report on Monday, October 16th. Zacks Investment Research raised Iqvia from a “hold” rating to a “buy” rating and set a $107.00 price target on the stock in a report on Wednesday, October 11th. Mizuho cut Iqvia from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a report on Thursday, November 9th. Finally, TheStreet raised Iqvia from a “c+” rating to a “b” rating in a report on Wednesday, December 13th. Seven equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Iqvia currently has a consensus rating of “Buy” and a consensus target price of $106.41.
Iqvia (IQV) traded up $0.29 during midday trading on Thursday, reaching $100.22. The company had a trading volume of 975,100 shares, compared to its average volume of 1,117,646. The stock has a market capitalization of $20,780.00, a P/E ratio of 345.59, a PEG ratio of 1.38 and a beta of 0.61. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29. Iqvia has a 12 month low of $74.80 and a 12 month high of $110.67.
In other news, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of Iqvia stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $102.00, for a total value of $764,776,314.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Ari Bousbib sold 46,080 shares of Iqvia stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $108.14, for a total value of $4,983,091.20. Following the completion of the sale, the insider now directly owns 1,036,839 shares in the company, valued at $112,123,769.46. The disclosure for this sale can be found here. Insiders sold 8,796,558 shares of company stock worth $897,717,008 over the last ninety days. Insiders own 6.40% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in shares of Iqvia in the fourth quarter worth about $209,000. Atria Investments LLC bought a new stake in Iqvia during the fourth quarter worth approximately $218,000. Fox Run Management L.L.C. bought a new stake in Iqvia during the fourth quarter worth approximately $250,000. Creative Planning bought a new stake in Iqvia during the fourth quarter worth approximately $450,000. Finally, Oakbrook Investments LLC bought a new stake in Iqvia during the fourth quarter worth approximately $652,000. 95.78% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: “Evercore ISI Begins Coverage on Iqvia (IQV)” was published by American Banking and Market News and is the sole property of of American Banking and Market News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/01/18/evercore-isi-begins-coverage-on-iqvia-iqv.html.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
